⏳ Fetching live dividend data...
Home › Calculator › EPGNY Dividend Calculator 2026
Epigenomics AG · OTC
Price: $2.39 · Annual div: $1.27/share · Frequency: quarterly · Payout ratio: 50% · Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in EPGNY → $2748529217.81M in 10 years · $228,623,265,551,298.38/month
Epigenomics AG is a molecular diagnostics firm specializing in non-invasive liquid biopsy methods to identify cancer at its earliest stages. Their flagship offering, Epi proColon, is a blood test designed for the timely screening of colorectal cancer and is available across the United States, Europe, and China. The company's portfolio also includes a blood test for hepatocellular carcinoma, alongside Epi BiSKit, a pre-analytical solution comprising reagents essential for preparing bisulfite-converted DNA. Through its robust research and development efforts, Epigenomics identifies relevant biomarkers within human tissue and then proceeds to develop and secure patents for associated in vitro diagnostic (IVD) blood tests. Established in 1998, Epigenomics AG maintains its corporate headquarters in Berlin, Germany.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open EPGNY position with:
Real after-tax yield depends on where you live and how you hold EPGNY.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 53.05% | 50.25% | $5,305 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 45.09% | 42.29% | $4,509 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 42.44% | 39.64% | $4,244 / yr |
| 🇬🇧 UK ISA | 0% | 53.05% | 50.25% | $5,305 / yr |
| 🇬🇧 UK Taxable | 8.75% | 48.41% | 45.61% | $4,841 / yr |
| 🇨🇦 TFSA | 0% | 53.05% | 50.25% | $5,305 / yr |
| 🇨🇦 CA Taxable | 25% | 39.79% | 36.99% | $3,979 / yr |
| 🇦🇺 Super (pension) | 15% | 45.09% | 42.29% | $4,509 / yr |
| 🇦🇺 AU Taxable | 30% | 37.13% | 34.34% | $3,713 / yr |
| 🇩🇪 DE Taxable | 26.375% | 39.06% | 36.26% | $3,906 / yr |
| 🇫🇷 FR Taxable | 30% | 37.13% | 34.34% | $3,713 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $1.27/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
EPGNY pays quarterly — 4 times per year. Next ex-div: TBD.
How EPGNY compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for EPGNY sourced from FMP /financial-growth endpoint — real data, not estimates.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the EPGNY dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Epigenomics AG (EPGNY) is currently trading at $2.39, trading near its 52-week low. The current dividend yield is 53.05% based on an annual payout of $1.27 per share.
Epigenomics AG (EPGNY) is a healthcare stock currently trading at $2.39 with a dividend yield of 53.05%. The company pays an annual dividend of $1.27 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
Auto-generated from live market data. For educational purposes only — not financial advice.
Real users. No sign-up required to leave a review.
“Finally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.”
“I've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly — $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.”
“Really solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.”
“As someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.”
“The Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.”
Reviews reflect users' personal experiences. Not financial advice.
Leave a review →If DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.
⏱️ Takes 30 seconds · No signup · Free forever